Societies

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Societies

Jennifer Plichta: Fabulous pre-meeting course at ASBRS24 on high risk breast patients

Photo from Jennifer Plichta/X

Apr 13, 2024, 11:36

Jennifer Plichta: Fabulous pre-meeting course at ASBRS24 on high risk breast patients

Jennifer Plichta, Breast surgeon at Duke, shared on X:

“Fabulous pre-meeting course at The American Society of Breast Surgeons 2024 (ASBRS24) on high-risk breast patients with Dr. Ashley Stuckey, Dr. Barry S. Rosen, Dr. Cory Donovan, Dr. Anita Johnson, and Jennifer Scalia GC!! Always learning new things!!”

Source: Jennifer Plichta/X

Anita Johnson ASBRS24 Ashley Stuckey Barry S. Rosen cancer Cory Donovan Jennifer Plichta Jennifer Scalia OncoDaily Oncology The American Society of Breast Surgeons 2024

Sep 12, 2024, 10:55

Sangam: Incredible learning experience at SBH Internal Medicine

Sep 12, 2024, 10:55

Amil Družic: "Improving the Assessment of Citizens' Perception of Risk" at the ESMO Congress 2024

Sep 12, 2024, 10:48

Panel on Early Detection and Cancer Prevention at Global Summit on Cancer Research and Entrepreneurship

Sep 12, 2024, 10:45

Last chance to register for the CityU-AFCR Symposium on Precision Medicine and Digital Medicine

Sep 12, 2024, 10:42

Narine Mnatsakanyan: Exciting times in the world of Oncology

Sep 12, 2024, 10:37

The GCR’s manifesto on ‘Improving cancer care in conflict-impacted populations’

Sep 12, 2024, 10:35

Paul Workman Honored with 2024 International Chemical Biology Society Global Lectureship Award

Sep 12, 2024, 10:29

John Haanen Honored with 2024 ESMO Lifetime Achievement Award

Sep 12, 2024, 10:24

Fumiko Ladd Chino: The dirty underbelly of the current health care environment

Sep 12, 2024, 10:16

M. Tezer Kutluk: Whatever you invest it will return to the life of children with cancer

Sep 12, 2024, 10:09

Experts in multiple myeloma weigh the benefits and risks of second malignancies following CAR-T in Multiple Myeloma - Cancer Network

Sep 12, 2024, 10:06

Rami Manochakian: The latest data in management of stage IV NSCLC at “Advancement in Oncology” event